Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...

It took decades to get to the GLP-1 breakthrough in obesity treatment. Now, the biopharma industry is clamoring over the field's next frontier: staving off the losses ...

Welcome to the healthier, happier world of 2030. Heart attacks and strokes are down 20%. A drop in food consumption has left ...

Cleveland Clinic expert discusses treatment options for obesity including weight loss drugs and bariatric surgery. Never miss ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

New drugs from public and private companies are expected to saturate the obesity drug market. Novo Nordisk and Eli Lilly are currently dominating the weight loss drug market, but biopharmaceutical ...

PHILADELPHIA — Roux-en-Y gastric bypass (RYGB) produces maximal weight loss in patients with obesity compared with other surgical procedures and with weight loss drugs, according to a meta ...

Oct. 25, 2024 — A new study has examined a large sample of privately insured patients with obesity and found ... Popular Diabetes and Weight-Loss Drug May Reduce Risk of Alzheimer's Disease ...

Teenagers with obesity ... a new study published on Monday. More fizkes / aprott/Getty Images / Canva Doctors have previously expressed concerns over young people taking GLP-1 weight loss drugs.

For Medicare, offering the new ... weight-loss drugs. The CBO team based its analysis on research studies, evidence from simulations and a review of the effects of bariatric surgery on actual ...

an episode of the popular cartoon comedy joked about the ongoing trend surrounding weight loss drugs. In the show, Eric is prescribed the drug Lizzo, which was called a “whole new obesity drug f ...